- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 48.73M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 54.03M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 42.95M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.13M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$6.43M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $10.06M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $14.64M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $28.04M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $8.33M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $13.44M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $26.03M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $26.85M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $16.24M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $15.67M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $46.03M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $46.24M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $27.42M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $31.77M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $54.35M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $59.68M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.12 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.10 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $6.62M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $8.26M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $624.1K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $1.03M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.45M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$4.45M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$6.13M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$9.32M |
| Revenue | Q1 2026 · Mar 31, 2026 | $8.16M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $3.05M |